These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10932464)

  • 1. Drug utilization review: mechanisms to improve its effectiveness and broaden its scope. The U.S. Pharmacopeia Drug Utilization Review Advisory Panel.
    J Am Pharm Assoc (Wash); 2000; 40(4):538-45. PubMed ID: 10932464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of inappropriate drug prescribing by computerized, retrospective DUR screening in Korea.
    Yeom JH; Park JS; Oh OH; Shin HT; Oh JM
    Ann Pharmacother; 2005 Nov; 39(11):1918-23. PubMed ID: 16219902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Michigan drug utilization review and OBRA 90.
    Sandusky M
    Mich Med; 1993 Apr; 92(4):38-9. PubMed ID: 8231930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug utilization review in the managed care environment.
    Briesacher B; DuChane J
    Med Interface; 1995 Mar; 8(3):72-4, 76-8. PubMed ID: 10141391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of drug utilization reviews on the quality of in-hospital prescribing: a quasi-experimental study.
    Grégoire JP; Moisan J; Potvin L; Chabot I; Verreault R; Milot A
    BMC Health Serv Res; 2006 Mar; 6():33. PubMed ID: 16536865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription drug utilization review in the private sector.
    Kralewski J; Wertheimer A; Ratner E
    Health Care Manage Rev; 1994; 19(2):62-71. PubMed ID: 8089024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ineffectiveness of retrospective drug utilization review.
    Hennessy S; Strom BL
    LDI Issue Brief; 2003 Sep; 9(1):1-4. PubMed ID: 14577443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of patient information on the quality of pharmacists' drug use review decisions.
    Warholak-Juarez T; Rupp MT; Salazar TA; Foster S
    J Am Pharm Assoc (Wash); 2000; 40(4):500-8. PubMed ID: 10932459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the prescription quality: hospital databases].
    Milot A; Grégoire JP; Moisan J
    Therapie; 1996; 51(3):249-52. PubMed ID: 8881116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interventions to improve the management of diabetes mellitus in primary health care and outpatient community settings].
    Hansen LJ; Drivsholm TB
    Ugeskr Laeger; 2002 Jan; 164(5):607-9. PubMed ID: 11871208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategic opportunities for effective optimal prescribing and medication management.
    Sketris IS; Langille Ingram EM; Lummis HL
    Can J Clin Pharmacol; 2009; 16(1):e103-25. PubMed ID: 19182305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderly.
    Starner CI; Norman SA; Reynolds RG; Gleason PP
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):11-9. PubMed ID: 19281936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacists' reactions to the Wisconsin Medicaid drug-use review program.
    Brown CM; Lipowski EE
    Am J Hosp Pharm; 1993 Sep; 50(9):1898-902. PubMed ID: 7907839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug utilization review in ambulatory settings: state of the science and directions for outcomes research.
    Lipton HL; Bird JA
    Med Care; 1993 Dec; 31(12):1069-82. PubMed ID: 8246637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the pilot program on the real-time drug utilization review system in South Korea.
    Heo JH; Suh DC; Kim S; Lee EK
    Int J Med Inform; 2013 Oct; 82(10):987-95. PubMed ID: 23910897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DUR applications in managed care.
    Navarro RP
    Med Interface; 1995 Mar; 8(3):67-8. PubMed ID: 10141390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A taxonomy for disease management: a scientific statement from the American Heart Association Disease Management Taxonomy Writing Group.
    Krumholz HM; Currie PM; Riegel B; Phillips CO; Peterson ED; Smith R; Yancy CW; Faxon DP;
    Circulation; 2006 Sep; 114(13):1432-45. PubMed ID: 16952985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.